Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

EBI Anti Sepsis B.V.

The Netherlands Kneuterdijk 2, 2514 EN Hague, The Netherlands

About the sponsor

EBI Anti Sepsis B.V. focuses on clinical research in coronary artery disease, with particular attention to patients undergoing coronary artery bypass grafting and related surgical care.

  • Coronary artery disease
  • Coronary artery bypass grafting
  • On-pump cardiac surgery

The sponsor’s current research activity is centered on postoperative outcomes in cardiac surgery, especially measures linked to recovery after major cardiovascular procedures.

About Specializations

EBI Anti Sepsis B.V. runs clinical trials in conditions such as Coronary artery disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Coronary artery disease

Not yet recruiting

A study to evaluate the effect of EA-230 on the hospital stay length for patients undergoing coronary artery bypass surgery for coronary artery disease.

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:(2S)-2-[[2-[[(2S)-5-AMINO-2-[[(2S)-2-AMINOPROPANOYL]AMINO]-5-OXOPENTANOYL]AMINO]ACETYL]AMINO]-3-METHYLBUTANOIC ACID
  • Sponsor:EBI Anti Sepsis B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.